A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vericel Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 26,514 shares of VCEL stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,514
Previous 26,894 1.41%
Holding current value
$1.5 Million
Previous $1.23 Million 9.16%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.25 - $53.56 $16,055 - $20,352
-380 Reduced 1.41%
26,514 $1.12 Million
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $1.12 Million - $1.42 Million
26,894 New
26,894 $1.23 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.68B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.